Cardiol Therapeutics Inc Class A (CRDL) short interest & short volume · 3.6% of float short
Cardiol Therapeutics Inc Class A official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
CRDL short interest fell 7.4% to 2.8M shares in the Oct 15, 2026 report (3.6% of float, 1.3 days to cover). Daily short volume averaged 40.2% of volume over the last 20 sessions, up from 39.0% the 20 sessions before, the 45th percentile of its own 20-day averages since Oct 6, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 2.8M
- prior 3.1M
- % of float
- 3.6%
- float 79.6M
- Days to cover
- 1.3
- avg vol 2.2M
- Change vs prior report
- -7.4%
| Report date | Shares short | $ value short | Change | % float | Days to cover | Price |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | 2.8M | $3.3M | -7.4% | 3.6% | 1.3 | $1.15 |
| Sep 30, 2026 | 3.1M | $5.1M | -7.3% | 3.9% | 3.1 | $1.66 |
| Sep 15, 2026 | 3.3M | $6.1M | +13.2% | 4.2% | 2.2 | $1.85 |
| Aug 31, 2026 | 2.9M | $5.8M | +26.7% | 3.7% | 1.6 | $1.98 |
| Aug 14, 2026 | 2.3M | $4.2M | +2.6% | 2.9% | 2.0 | $1.80 |
| Jul 31, 2026 | 2.3M | $2.9M | +1.9% | 2.8% | 2.3 | $1.27 |
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 11)
- 45.9%
- 96K of 209K
- 20-day average
- 40.2%
- prior 39.0%
- Percentile vs own history
- 45th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 11, 2026
Short squeeze score (model)
Price since settlement: -9.6%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
CRDL's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · CRDL overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-11 | 96,058 | 209,351 | 45.9% |
| 2026-11-10 | 54,605 | 120,471 | 45.3% |
| 2026-11-09 | 55,893 | 205,704 | 27.2% |
| 2026-11-06 | 130,014 | 301,246 | 43.2% |
| 2026-11-05 | 300,545 | 466,653 | 64.4% |
| 2026-11-04 | 242,725 | 592,785 | 41.0% |
| 2026-11-03 | 62,217 | 182,407 | 34.1% |
| 2026-11-02 | 110,360 | 333,960 | 33.0% |
| 2026-10-30 | 139,070 | 373,030 | 37.3% |
| 2026-10-29 | 78,902 | 288,622 | 27.3% |
Healthcare peers with similar quant ratings
CRDL among 545 rated Healthcare stocks (Lician quant rating, Nov 13, 2026). How the rating works
- KNSA short interest5.00 · Strong Buy · stock
- QTTB short interest4.99 · Strong Buy · stock
- AVAH short interest4.98 · Strong Buy · stock
- CDNA short interest4.97 · Strong Buy · stock
- EWTX short interest4.97 · Strong Buy · stock
- SNY short interest4.96 · Strong Buy · stock
- REGN short interest4.95 · Strong Buy · stock
- BTSG short interest4.94 · Strong Buy
CRDL short interest FAQ
What is CRDL's short interest?
Cardiol Therapeutics Inc Class A (CRDL) had 2.8M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 3.6% of its 79.6M-share float.
How many days to cover does CRDL have?
1.3 days: 2.8M shares short divided by an average daily volume of 2.2M for the Oct 15, 2026 period.
Is CRDL short interest rising or falling?
CRDL short interest fell (-7.4%) from 3.1M to 2.8M shares in the Oct 15, 2026 report.
Is CRDL a short squeeze candidate?
Lician's squeeze watch scores CRDL 8 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 4.8/40, days to cover 3.3/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of CRDL daily volume is sold short?
40.2% on average over the last 20 sessions to Nov 11, 2026 (FINRA Reg SHO daily short volume; the 45th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was CRDL's latest FINRA short volume?
On Nov 11, 2026, cached FINRA short volume for Cardiol Therapeutics Inc Class A (CRDL) was 96,058 shares, 45.9% of 209,351 total volume.
How many CRDL short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Cardiol Therapeutics Inc Class A (CRDL), from Oct 29, 2026 through Nov 11, 2026.
How did CRDL short volume percent change from the prior cached session?
Cached FINRA short volume for Cardiol Therapeutics Inc Class A (CRDL) moved from 45.3% on Nov 10, 2026 to 45.9% on Nov 11, 2026, up 0.6 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.